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Abstract
Background: Selenium is one of the trace minerals whose deficiency is known to lead to complications of female
reproduction. The identified gaps in researches regarding selenium and pregnancy include optimizing the dosage
of selenium supplementation, timing of supplementation, finding the best form and type of selenium, and
selenium administration combined with other antioxidants. Hence, this study was conceptualized to address one
of the identified gaps, that is, to find out the best timing of selenium administration around the time of pregnancy.
Specifically, this study aimed to assess the effects of maternal Selenium-supplementation, administered at various
stages of periconception period, on murine blastocyst morphology, percent occurrence of good quality blastocysts,
and implantation status.
Methods: ICR female mice were randomly assigned into the unsupplemented group (Group I) receiving basal
diet without selenium, and treatment groups given with 3.0 μg selenium-supplement per day during pregestation only
(Group II), pregestation-throughout-gestation (Group III) and gestation only (Group IV). Both blastocyst morphology and
implantation status were assessed.
Results: The morphometric measurements of blastocysts appeared to be unaffected by selenium-supplementation at
different stages of periconception. Selenium-supplementation at pregestation only (Group II) and gestation only (Group
IV) produced higher percent occurrence of good quality blastocysts and lower percent pre-implantation loss than
Group III. Among all the treatment groups, Group III (Selenium-supplementation during pregestation-to-gestation)
yielded the lowest quality blastocysts and highest percent pre-implantation loss.
Conclusion: Maternal selenium-supplementation during pregestation and gestation stages of the periconception
period yielded a high percent occurrence of good quality blastocysts and pre-implantation success.
Keywords: Blastocyst morphometry, Periconception period, Pre-implantation loss, Post-implantation loss, Trace mineral,
Selenium-supplementation
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Background
Selenium is a trace element with an important role in anti-
oxidative protection [1–7]. It is a component of selenocys-
teine incorporated in diverse array of antioxidative
selenoenzymes that include glutathione peroxidase and
thioredoxin reductase, which reduce the excessive levels of
reactive oxygen species (ROS) [1, 8–11]. At present, there
are reports on reproductive and pregnancy complications
as outcomes of selenium deficiency [2, 3, 12, 13]. However,
there are insufficient evidences about the capability of sel-
enium supplementation in preventing reproductive health
and pregnancy disorders [11, 12]. In fact, there are only
limited research trials of selenium supplementation during
pregnancy [1, 11]. More intervention trials are recom-
mended to determine the beneficial effects of selenium to
pregnancy outcomes [12, 13].
One of the identified gaps among studies regarding
selenium and reproductive health is optimizing the best
timing of supplementation [3]. This lack of information
about selenium is supported by other research studies
recommending further investigation on the effects of
timing of micronutrient administration on pregnancy
outcomes [14, 15]. Hence, this present study addresses
this gap by finding out the best timing of selenium
administration during pregnancy, which refers to the
different stages of periconception period.
Moreover, to respond with one of the United Nations
Millennium Development Goals (MDG), that is, improving
pregnancy outcome by optimizing the mother’s nutritional
status [16], and to mitigate the alarming state of maternal
deaths caused by pregnancy complications, this study aims
to assess the effects of maternal Selenium-supplementation
at varying stages of periconception period on murine
blastocyst morphometric parameters, percent occurrence
of good quality blastocysts, and implantation status. It is
with hope that maternal selenium supplementation might




Selenium tablets, containing 200 μg of selenium yeast,
were bought from one of the General Nutrition Centers
(GNC) Live Well Health Stores in Metro Manila,
Philippines. All other chemicals and reagents were pur-
chased from other scientific chemical suppliers.
Test animals and maintenance
Fifty six (56) seven-week old ICR female mice and twenty-
eight 15–20 week old ICR male mice, approximately 30.0
g of weight were obtained from the stock bred of the
Marine Science Institute – Natural Products Laboratory,
University of the Philippines, Diliman. All mice were kept
individually in standard - sized cages in the animal house
of Department of Biology at De La Salle University –
Manila, where they were acclimatized for two weeks
maintaining at 12 h light: 12 h dark cycle with 28–30 °C
ambient temperature. Once a week, all animal cages were
sanitized, beddings were autoclaved and replaced, feed
plates and water bottles were also washed
An adult mouse of 25.0 to 30.0 g weight consumes 3.0
to 6.0 g of food pellet per day [17]. Hence, all mice were
given 6.0 g of food pellets per day. They had access to
purified drinking water ad libitum.
The standard basal diet are in the form of food pellets
that are available in the local pet markets in the
Philippines. This is composed of wheat bran, soybean
hull, soybean meal, corn, rice, alfalfa, full fat soybean,
and yucca extract. Guaranteed analysis shows that these
are composed of 18.0% crude protein, 16.0% crude fiber,
2.5% crude fat, 10.0% moisture, 10.0% ash, 0.9% calcium,
and 0.7% phosphorus. Other macro- and micronutrients
include the following: fructo-oligosaccharide, vitamin A
acetate, vitamin B12 supplement, vitamin D3 supplement,
folic acid, biotin, choline chloride, tocopheryl acetate,
menadione sodium bisulfate, ascorbic acid, nicotinic acid,
calcium-D-panthothenate, riboflavin-5′-phosphate sodium,
thiamine hydrochloride, pyridoxine hydrochloride, calcium
carbonate, potassium iodide, sodium chloride, monocal-
cium phosphate, ferrous sulfate, zinc oxide, manganous
oxide, and copper sulfate.
The handling and maintenance of laboratory test ani-
mals adhered to the Rules, Regulations, and Guiding
Principles of the Veterinary Medical Association’s safety
standards of the Philippines and Philippine Association
for Laboratory Animal Science.
The experimental design
The study consisted of two phases; the assessments of
blastocyst morphology (phase I) and implantation status
(phase II).
After the acclimatization period, at which time the
females were already sexually mature, were then ran-
domly assigned into four groups with 14 members each.
Two mice per group were used for phase I and twelve
mice per group for phase II.
For the unsupplemented group (Group I), all were given
with basal food pellets (6.0 g food pellet/day) without sel-
enium supplement. For the treated groups, the timing for
selenium administration were as follows: for the pregesta-
tion treatment group (Group II), females were given with
basal food pellets + 3.0 μg selenium supplement per day
for three weeks only before mating; for the pregestation-
to-gestation treatment group (Group III), all were also
given with diet similar with that of Group II for three
weeks before mating, but females in phase I and phase II
were continuously given with similar diet for 4 days and
16 days after mating respectively; for the gestation
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treatment group (Group IV), all mice were given with diet
similar with Group II and III, but females in phase I and
phase II were only given with the diet for 4 days and 16
days after mating respectively.
Mating was allowed to take place at the end of the third
week (22nd day). Each cage had 1 male with 2 females. To
determine pregnancy, the females were checked for the
presence of vaginal copulatory plugs from 0700 to 0800 h.
Females that were found positive for vaginal plugs were
placed in separate cages and their embryos were consid-
ered as 0.5 day post coitum (dpc) [7].
For phase I, embryo retrieval was performed at 4.5 dpc
for blastocyst morphology assessment. For phase II,
ovaries and uteri samples were obtained at 16.5 dpc for
implantation success assessment.
Treatment administration
Selenium supplementation was administered everyday via
dietary route. The selenium supplement was prepared by
dissolving a 200 μg selenium yeast tablet in 10 mL mineral
water to yield 3.0 μg selenium in 0.15 mL solution.
It is the 0.15 ml solution that was coated into 2.0 g
food pellets, which was given as initial consumption for
the day to ensure that the whole supplement was
consumed.
After the initial consumption, the remaining 4.0 g food
pellets was supplied in full. The dose of selenium supple-
ment in this study was computed based on the dosage
used by Soudani et al. [18], which is 0.5 mg selenium/kg
diet. This selenium dosage was proven to provide protec-
tion against oxidative stress and damage in rats.
Phase I: blastocyst morphology assessment
Two female mice per group were sacrificed by cervical
dislocation on 4.5 dpc. Blastocysts were recovered by
flushing the uterus with M2 medium under a stereo-
microscope. The recovered blastocysts were observed
under an inverted microscope (Nikon Eclipse TS100)
and were photographed using digital sight camera at
400x and 600x magnification.
The images of blastocysts at 600x magnification
were analyzed using the Image J software (Fig. 1).
The morphometric parameters that were measured
using ‘line and oval selection tools’ are as follows:
mean embryo diameter (MED), mean zona pellucida
diameter (MZPD), embryo area (EA), zona pellucida
area (ZPA), embryo perimeter (EP), and zona pellu-
cida perimeter (ZPP) [19, 20].
The collected embryos were classified accordingly on
stages of development based on the Manual of the Inter-
national Embryo Transfer Society (IETS) about ‘A pro-
cedural guide and general information for the use of
embryo transfer technology emphasizing sanitary proce-
dures’ [21]. Since all embryos were collected on 4.5 dpc,
these were classified into three categories that were de-
scribed as follows: compact morula with early cavitation
Fig. 1 Photomicrographs of blastocysts (arrows) at 600x magnification being measured using the Image J software. a Unsupplemented group,
b Pregestation only group, c Pregestation-to-gestation group, d Gestation only group
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(stage 4); early blastocyst (stage 5) described with the
presence of blastocoele occupying less than half of the
embryo; mid-blastocyst (stage 6) described with the
presence of blastocoele occupying more than half or en-
tirely fills the embryo [22, 23].
Blastocyst quality was scored and evaluated based also
on the guidelines of the IETS Manual. The three classifi-
cations of blastocyst quality were excellent or good
(score 1), fair (score 2), and poor (score 3) [21, 24]. The
descriptions in each classification were determined
through thresholding or binary contrast enhancement
using Image J software on embryo images taken at 400x
magnification.
Phase II: implantation status assessment
On 16.5 dpc, twelve females per group were sacrificed
by cervical dislocation. Uteri and ovaries were obtained,
and were assessed for the number of implantations,
foetuses, and corpora lutea.
Ovaries were fixed in 10% buffered formalin overnight
and were brought to the Philippine Kidney Dialysis
Foundation for standard histological preparations using
hematoxylin and eosin stain. Ovaries were observed
under an inverted microscope (Nikon Eclipse TS100) to
determine the number of corpora lutea. The percent
pre-implantation loss per female was calculated using
this formula [25–27].
Table 1 Morphometric parameters of mice blastocysts from all groups













Group I 12 21.20±0.93 25.17±1.07 376.18±33.81 509.38±41.63 68.01±3.13 79.31±3.33
Group II 15 19.86±0.59a 22.94±0.61a 317.94±18.97a 418.83±21.36a 62.90±1.71a 72.30±1.69a
Group III 13 18.60±0.58a 21.65±0.54a* 275.28±15.02a* 376.46±18.32a* 58.57±1.65a* 68.56±1.72a*
Group IV 20 20.21±0.43a 23.49±0.44a 301.94±12.41a* 422.88±15.13a 61.39±1.24a 72.70±1.27a
Values are given as mean±SEM. n = number of blastocyst
Values with the same letters in the treatment groups within column are not significantly different
Values in the treatment groups with asterisk are significantly different from the unsupplemented group
Group I (Unsupplemented group), Group II (Pregestation only group), Group III (Pregestation-to-gestation group), and Group IV (Gestation only group)
Fig. 2 Photomicrographs of good quality blastocysts (arrows) at 400x magnification. a Unsupplemented group (Group I), b Pregestation only
group (Group II), c Pregestation-to-gestation group (Group III), and d Gestation only group (Group IV)
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% Pre‐implantation loss ¼ TCL – TISð Þ=TCL½  x 100
where : TCL ¼ total number of corpora lutea
TIS ¼ total number of implantation sites
Implantation sites were assessed by immersing the
uteri into 2% sodium hydroxide (NaOH) solution until
the sites become visible and clear. Implants were classi-
fied as follows: viable fetuses have distinct fetal capsule
and placenta [28]; non-viable fetuses are underdeveloped
and smaller than viable fetuses [27, 29] with identifiable
ischemia or hemorrhage [28]; and resorptions or re-
sorbed embryos described as small, round, black or dark
brown masses, which are signs of necrosis [29]. Percent
post–implantation loss per female was determined using
this formula [27, 29].
% Post–implantation loss ¼ TIS – NVFð Þ=TIS½  x 100
where : TIS ¼ total number of implantation sites
NVF ¼ number of viable fetuses
Statistical analysis
Statistical differences of data on blastocyst morphology
among groups were analyzed by one-way analysis of
variance (ANOVA) followed by post-hoc Tukey HSD test.
Blastocysts were classified or scored based only on quali-
tative assessment. Percent pre- and post-implantation
losses were analyzed using non-parametric Kruskal-Wallis
test, and Mann Whitney test to determine the specific
pairs of experimental groups with significant differences.
Data were presented as mean ± SEM (standard error of
the mean). All statistical tests were conducted using
Statistical Package for the Social Sciences (SPSS) Version




Three developmental stages of blastocysts were identified
in the study. These were stage 4, characterized as compact
morula with cavitation; stage 5, characterized as early
blastocyst having blastocoele occupying less than half of
the embryo; and stage 6, characterized as mid-blastocyst
having blastocoele occupying more than half of the
embryo.
Morphometric measurements of blastocysts and
occurrence of good quality blastocysts
Group III exhibited the lowest values of all the morpho-
metric parameters (Table 1). Most of these parameters
were significantly lower than Group I but not from those
of treatment Groups II and IV.
Percent occurrences of good (Fig. 2), fair (Fig. 3), and
poor (Fig. 4) quality blastocysts are shown in Table 2.
Group IV showed the highest percent occurrence of
Fig. 3 Photomicrographs of fair quality blastocysts (arrows) at 400x
magnification. a Unsupplemented group (Group I), b Pregestation
only group (Group II), and c Pregestation-to-gestation group
(Group III)
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good quality blastocysts followed by Group II. Groups I
and III were comparably low (Table 2; Figs. 2, 3, and 4).
Implantation losses
The number of corpora lutea determined through
hematoxylin and eosin (H&E) staining of ovaries is
shown in Fig. 5 with representative histophotographs
that are shown in Fig. 6. This reproductive outcome
among pregnant mice is used to compute for percent
pre-implantation loss.
Group II significantly exhibited the lowest percent
pre-implantation loss followed by Group IV. Both of
these groups exhibited significantly lower percent pre-
implantation loss than that of Group I. Group III had
the highest percent pre-implantation loss among those
of the treatment groups. It is significantly different from
that of Group II but not from that of Group IV (Fig. 7).
The percent post-implantation loss that was assessed
from the implantation sites in the uteri which were
classified as viable fetuses, non-viable fetuses, and re-
sorbed embryos (Figs. 8, 9, 10 and 9, respectively)
showed no significant differences among all groups
(Fig. 11).
Discussion
The results of the blastocyst morphometric measurements
may indicate that selenium-supplementation at varying
stages of periconception has not strongly influenced these
morphological parameters. It appears however, that a lon-
ger period of supplementation (25 days for Group III) may
have a tendency towards yielding smaller-sized blastocysts.
These selected morphometric parameters are variables
that seems to be not sensitive to the effects of varying the
stages of maternal selenium-supplementation.
The highest percent occurrence of good quality blas-
tocysts, that is, the lowest number of poor quality blas-
tocysts in Group IV may indicate that the best
periconception stage for selenium-supplementation to
ensure good quality blastocysts is during gestation
stage. It must be taken into consideration however, that
percent occurrence in Group II, is high as well relative to
Group III and Group I. Thus, selenium-supplementation
either during pregestation only or gestation only may have
Fig. 4 Photomicrographs of poor quality blastocysts (arrows) at 400x magnification. a Unsupplemented group (Group I), b Pregestation only
group (Group II), c Pregestation-to-gestation group (Group III), and d Gestation only group (Group IV)
Table 2 Percent occurrence of three classification of blastocyst
quality following the guidelines of the IETS Manual
Groups n Actual blastocyst count (Percent Occurrence %)
Good (1) Fair (2) Poor (3)
Group I 12 4 (33.3) 6 (50) 2 (16.67)
Group II 15 11 (73.3) 3 (20) 1 (6.7)
Group III 13 5 (38.5) 4 (30.8) 4 (30.8)
Group IV 20 19 (95) 0 1 (5)
n = number of blastocyst
Percent in parenthesis
Group I (Unsupplemented group), Group II (Pregestation only group), Group III
(Pregestation-to-gestation group), and Group IV (Gestation only group)




























Fig. 5 Number of corpora lutea obtained from H&E stained ovaries from all groups. Values are given as mean ± SEM. Group I (Unsupplemented group),
Group II (Pregestation only group), Group III (Pregestation-to-gestation group), and Group IV (Gestation only group)
Fig. 6 Histological cross – sections of ovaries showing the corpora lutea (CL) from all groups at 40x magnification. a Unsupplemented group,
b Pregestation only group, c Pregestation-to-gestation group, d Gestation only group









































Fig. 7 Percent pre-implantation loss among groups. Values are given as mean ± SEM. Values with the same letters are not significantly different.
Group I (Unsupplemented group), Group II (Pregestation only group), Group III (Pregestation-to-gestation group), and Group IV
(Gestation only group)
Fig. 8 Photographs of 16.5 dpc murine uterine horns with 100% viable fetuses (arrows). a Unsupplemented group, b Pregestation only group,
c Pregestation-to-gestation group, d Gestation only group
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similar influence on yielding good quality blastocysts. This
is further supported by the abovementioned smaller-sized
embryos in Group III (Table 1), which is also the group
that has the lowest percent occurrence of good quality
blastocysts among all treatment groups.
Probably, the antioxidant system during these stages of
periconception could have been enhanced by selenium-
supplementation. The enhancement of antioxidant system
can mitigate oxidative stress that increases during preg-
nancy because of an upsurge in maternal metabolic demand
for energy production [30, 31]. Pregnancy leads to reactive
oxygen species (ROS) formation that once it reached exces-
sive levels causes detrimental effects on normal cellular
functions [10, 30]. Based on many other studies, excessive
ROS is damaging on normal female reproduction, specific-
ally on embryo development [10, 32–34].
During selenium-supplementation, this micronutrient
is incorporated in the selenocysteine of antioxidative
selenoproteins that include isoforms of glutathione per-
oxidases (GPXs) and thioredoxin reductases (TrxRs),
selenoprotein P and selenoprotein W [3–6, 8, 35].
Selenium-supplementation during pregestation only or
gestation only could have embryoprotective capacity on
the deleterious impacts and influences of ROS on the
structure and function of cellular macromolecules, cell
membrane and mitochondria, thus preventing abnormal
and delayed embryo development [10, 36–40].
The high percent occurrence of poor quality blastocysts
in Group I (Unsupplemented group) may be attributed to
the lower levels of antioxidants than those of the supple-
mented groups. Poor quality blastocysts were reported as
could be due to lower levels of antioxidants [36].
The low percent occurrence of good quality blastocyst in
Group III possibly shows the toxic effects or ineffective in-
fluence of long-term selenium supplementation. Selenium
has many beneficial effects to animal and human health,
but this trace mineral still has reported cases of toxicity [3,
6, 41, 42], when given in high dose [43] or in long-duration
[44, 45]. Taking into consideration that the selenium dose
used in this study is at a level established to have a protect-
ive effect based from Soudani et al., [18], the 25 days (preg-
estation-to-gestation) of selenium-supplementation might
have caused a certain level of toxicity.
It was reported that long-term selenium-supplementation
does not result to the optimal levels and actions of seleno-
proteins, but led to the overexpression of these
Fig. 9 Photographs of 16.5 dpc murine uterine horns showing viable and non-viable (arrows) fetuses. a Unsupplemented group, b Pregestation
only group, c Pregestation-to-gestation group, d Gestation only group
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antioxidant proteins resulting further to the develop-
ment of insulin resistance, hyperglycemia, and hyperin-
sulinemia [5, 45, 46]. Specifically, the overexpression of
glutathione peroxidase 1 has undesirable effects to in-
sulin- induced signaling pathways consequently pro-
moting type 2 diabetes mellitus [46]. Thus, when this
metabolic disorder occurs during pregnancy, ROS is
produced [3], therefore risking the normal develop-
ment of blastocysts.
Long-term selenium-supplementation could also affect
the metabolic clearance rate of selenium, which is also
influenced by the type of selenium supplement that is
administered. Selenium-enriched yeast, the form of
selenium supplement used in this study, is highly rich in
selenomethionine (SeMet) [47, 48]. Reports show that
SeMet is highly absorbed in the small intestine through
methionine transporter system, and highly retained and
accumulated in the organs [48–51] such as skeletal
muscles, kidneys, liver, and pancreas [3, 49]. The SeMet
received by female mice from selenium-enriched yeast in
this study, could have lowered the excretion or the
metabolic clearance rate of selenium. Further, it might
have been intensified by the long-term selenium-
supplementation for 25 days (pregestation-to-gestation).
As a consequence, the accumulated selenium levels in
the organs contributed by the organic selenium form
and the selenium levels contributed by the prolonged
supplementation may possibly induce embryotoxic
effects to pre-implantation stage embryos, specifically to
blastocysts.
The maternal selenium level damaging to blasto-
cyst development possibly enhanced by lower meta-
bolic clearance rate is not caused by the decline in
renal hemodynamics that occurs only during the
last stages of pregnancy [52, 53]. In fact, early
stages of pregnancy are described with an increase
in glomerular filtration rate and renal hemodynamic
flow [50, 54]. Therefore, the possible lower excre-
tion rate of selenium in female mice in this study
might be an effect on the use of organic selenium
supplement aggravated by long-term selenium
supplementation.
The report on the reduced ovulation and implantation,
and few live fetuses in rats injected intraperitoneally with
high dose of sodium selenite (4.0 mg/kg body weight) [55]
supports the findings of this study that selenium beyond
the desired status in the maternal body could have detri-
mental effects to embryonic development.
Fig. 10 Photographs of 16.5 dpc murine uterine horns showing viable fetuses and resorptions (arrows). a Unsupplemented group, b Pregestation
only group, c Pregestation-to-gestation group, d Gestation only group
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Pre-implantation status was also evidently supported
by selenium-supplementation in Group II. Considering
that Group II is not significantly different from that of
Group IV, selenium-supplementation in these pericon-
ception stages could possibly lower percent pre-
implantation loss. These results in pre-implantation
status of Group II and Group IV are supported by the
incurred high percent occurrence of good quality blas-
tocysts (Table 2) in these two periconception stages.
Blastocysts with good quality have higher competency
for successful implantation [23, 56] which is the pri-
mary determinant for successful pregnancy [57].
Aside from blastocyst quality, successful implant-
ation depends on the endometrial receptivity to the
blastocyst [56, 58, 59]. Group II having the lowest
percent pre-implantation loss among groups, suggests
that selenium-supplementation during pregestation
only could have prepared the uterine endometrium
for implantation. Since pregnancy results to a decline
in glutathione peroxidase (GPx) activity [1, 3, 13],
selenium-supplementation during this periconception
stage could increase the levels of glutathione peroxid-
ase before and during the early onset of pregnancy.
Specifically, the isoform of GPx involved in blastocyst
implantation is glutathione peroxidase 3 (GPx3,)
which was upregulated for human endometrial recep-
tivity [58], and was abnormally expressed among
women who experienced implantation failure [59].
Thus, selenium-supplementation during this stage can
possibly prepare and improve blastocyst implantation
by enhancing the level and activity of GPx3. This
selenoprotein prepares the endometrium for implant-
ation by protecting the uterine cells and embryos
from excessive ROS such as hydrogen peroxides and
organic hydroxyperoxides [60].
Aside from GPxs, selenium-supplementation at preg-
estation stage and gestation stage can enhance the levels
and activities of thioredoxin reductases (TrxRs), which
are selenoproteins involved in reducing and maintaining
the levels of small antioxidative protein known as thiore-
doxin [3, 6, 10]. This reduced state protein makes devel-
oping embryos resistant from the damages of oxidative
stress [10] that in turn could promote association of
blastocysts with the endometrial lining. The favorable
results of selenium-supplementation during pregestation
was supported by Kind [61], which states that since poor
macro- and micronutrient status of the mother before
conception has tremendous impact to the establishment
of pregnancy, supplementation of these nutrients before
pregnancy can prepare the maternal body in supporting
normal embryonic development.
The high percent pre-implantation loss in Group III,
though not significantly higher than that of Group IV,
but significantly higher than that of Group II
strengthens the findings that selenium-supplementation
during pregestation-to-gestation produces the lowest
quality of blastocysts among treatment groups, which
may lower the chance of successful implantation.
Conclusions
The overall findings of the present study indicate that
pregestation only and gestation only are the best peri-
conception stages for selenium-supplementation to yield










































Fig. 11 Percent post-implantation loss among groups. Values are given as mean ± SEM. Values with the same letters are not significantly
different. Group I (Unsupplemented group), Group II (Pregestation only group), Group III (Pregestation-to-gestation group), and Group IV
(Gestation only group)
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